← back to search

Xiaotian Yuan

Northwest University · US
Area of research
Physiology · Molecular Biology
Research interest
Research interests include Telomeres, Telomerase, and Senescence, Epigenetics and DNA Methylation, Bladder and Urothelial Cancer Treatments, and Ferroptosis and cancer prognosis.
h-index
21
citations
1,809
works
47
NIH funding
primary concept
email

Recent publications

Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features
Cancers 2022cited by 34position: middledoi
FKBP4 integrates FKBP4/Hsp90/IKK with FKBP4/Hsp70/RelA complex to promote lung adenocarcinoma progression via IKK/NF-κB signaling
Cell Death and Disease 2021cited by 62position: middledoi
Telomere-related Markers for Cancer
Current Topics in Medicinal Chemistry 2020cited by 80position: firstdoi
TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends
Cancer Letters 2020cited by 69position: firstdoi
PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma
Cancers 2020cited by 33position: middledoi
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players
Oncogene 2019cited by 465position: firstdoi
GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer
Cell Death and Differentiation 2019cited by 73position: middledoi
Telomerase Reverse Transcriptase (TERT) in Action: Cross-Talking with Epigenetics
International Journal of Molecular Sciences 2019cited by 71position: firstdoi
GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression
Oncogene 2018cited by 84position: firstdoi
Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma
Cancer Letters 2018cited by 59position: middledoi
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications
Genes 2016cited by 139position: middledoi
TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR
Oncotarget 2014cited by 73position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Dawei Xu · Karolinska University Hospital11 papers (2014–2022)Catharina Larsson · Karolinska University Hospital4 papers (2018–2022)Feng Kong · Shandong University4 papers (2014–2019)Klas Strååt · Karolinska University Hospital4 papers (2018–2022)Ninni Mu · Karolinska University Hospital3 papers (2018–2022) · 3 papers (2019–2020)Magnus Björkholm · Svenska Örtmedicinska Institute3 papers (2014–2019)C. Christofer Juhlin · Karolinska University Hospital3 papers (2018–2022)Tiantian Liu · Beijing University of Posts and Telecommunications3 papers (2014–2018)Xiangling Xing · Qilu Hospital of Shandong University2 papers (2020–2022)Yanxia Guo · Zhejiang Chinese Medical University2 papers (2018–2019)Guanghui Cheng · Shandong University2 papers (2018–2019)Na Wang · Fudan University2 papers (2018–2020)Lu Zhang · Rutgers, The State University of New Jersey2 papers (2018–2019)Shengtian Zhao · Shandong University2 papers (2014–2019)Yujiao Wu · Shanghai Medical College of Fudan University1 papers (2019–2019)Tomas J. Ekström · Karolinska Institutet1 papers (2018–2018)Shuai Zong · Shandong University1 papers (2021–2021)Adam Stenman · Karolinska University Hospital1 papers (2018–2018)Yu Xia · Shandong University1 papers (2021–2021)